Key Takeaways BSX's recent acquisitions enhanced CRM, Endoscopy, Interventional Cardiology, Oncology and EP portfolios.BSX's acquisitions drove 420 bps of Q3 sales growth, lifting organic revenues to 15.3% above guidance.Boston Scientific advanced its Neuromodulation reach with an agreement to acquire all of Nalu Medical.Over the past several years, Boston Scientific (BSX) has pursued a series of acquisitions in support of its growth strategy, both strengthening its core businesses and expanding into high-g ...